Latest AI and machine learning research in dementia for healthcare professionals.
BACKGROUND: Protein abundance levels, sensitive to both physiological changes and external interventions, are useful for assessing the Alzheimer's disease (AD) risk and treatment efficacy. However, identifying proteomic prognostic markers for AD is challenging by their high dimensionality and inherent correlations.
The patch clamp technique is a fundamental tool for investigating ion channel dynamics and electrophysiological properties. This study proposes the first artificial intelligence framework for characterizing multiple ion channel kinetics of whole-cell recordings. The framework integrates machine learning for anomaly detection and deep learning for multi-class classification. The anomaly detection e...
BACKGROUND: Dementia is a major public health challenge in modern society. Early detection of high-risk dementia patients and timely intervention or t...
Diabetes Mellitus combined with Mild Cognitive Impairment (DM-MCI) is a high incidence disease among the elderly. Patients with DM-MCI have considerab...
Alzheimer's disease (AD) is a neurodegenerative disorder characterized by limited effective treatments, underscoring the critical need for early detec...
Alzheimer's disease (AD) is a neurodegenerative disorder. It causes progressive degeneration of the nervous system, affecting the cognitive ability of...
Cerebral microbleeds (CMB) represent a feature of cerebral small vessel disease (cSVD), a prominent vascular contributor to age-related cognitive decl...
Alzheimer's disease (AD) is a brain disorder that causes memory loss and behavioral and thinking problems. The symptoms of Alzheimer's are similar thr...
Proteome changes associated with APOE4 variant carriage that are independent of Alzheimer's disease (AD) pathology and diagnosis are unknown. This stu...
Alzheimer's Disease (AD) is a debilitating neurodegenerative disease that affects 47.5Â million people worldwide. AD is characterised by the formation ...
BACKGROUND: To diagnose Alzheimer disease (AD), individuals are classified according to the severity of their cognitive impairment. There are currentl...
Elucidating Alzheimer's disease (AD) prodromal symptoms can resolve the outstanding challenge of early diagnosis. Based on intrinsically related subst...
[This corrects the article DOI: 10.1177/25424823241289804.].
The disease amyloid plaques, neurofibrillary tangles, synaptic dysfunction, and neuronal death gradually accumulate throughout Alzheimer's disease (AD...
Correctly diagnosing Alzheimer's disease (AD) and identifying pathogenic brain regions and genes play a vital role in understanding the AD and develop...
Alzheimer's disease (AD), the most common neurodegenerative disorder world-wide, presents sex-specific differences in its manifestation and progressio...
Alzheimer's disease (AD), a neurological disorder, is one of the major reasons for memory loss in the world. AD is characterized by a sequela of cogni...
BACKGROUND: Alzheimer's disease (AD) has a major negative impact on people's quality of life, life, and health. More research is needed to determine t...
BACKGROUND: Alzheimer's Disease is a neurodegenerative condition leading to irreversible and progressive brain damage, with possible features such as ...
Dementia probably due to Alzheimer's disease is a progressive condition that manifests in cognitive decline and impairs patients' daily life. Affected...